This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Ferritarg

Alissa Pharma, LLC

Drug Names(s): 90Y antiferritin polyclonal antibody, Ferritarg P, Yttrium (90Y) antiferritin, Y90-anti-ferritin

Description: Ferritarg is an yttrium 90-conjugated anti-ferritin rabbit polyclonal antibody. (The antibody is conjugated to Indium 111 for diagnostic use.)

Deal Structure: Ferritarg was originally developed at two US institutions, Johns Hopkins and MD Anderson, and by MAT Biopharma (formerly Monoclonal Antibodies Therapeutics; now MABLife).

Alissa Pharma owns the worldwide rights for Ferritarg in all radiopharmaceutical indications.


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug